Your browser doesn't support javascript.
loading
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation.
Villatoro, Alicia; Cuminetti, Vincent; Bernal, Aurora; Torroja, Carlos; Cossío, Itziar; Benguría, Alberto; Ferré, Marc; Konieczny, Joanna; Vázquez, Enrique; Rubio, Andrea; Utnes, Peter; Tello, Almudena; You, Xiaona; Fenton, Christopher G; Paulssen, Ruth H; Zhang, Jing; Sánchez-Cabo, Fátima; Dopazo, Ana; Vik, Anders; Anderssen, Endre; Hidalgo, Andrés; Arranz, Lorena.
Afiliação
  • Villatoro A; Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH2 building level 10, 9019, Tromsø, Norway.
  • Cuminetti V; Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH2 building level 10, 9019, Tromsø, Norway.
  • Bernal A; Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH2 building level 10, 9019, Tromsø, Norway.
  • Torroja C; Bioinformatics Unit, Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029, Madrid, Spain.
  • Cossío I; Area of Cell and Developmental Biology, CNIC, 28029, Madrid, Spain.
  • Benguría A; Genomics Unit, CNIC, 28029, Madrid, Spain.
  • Ferré M; Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH2 building level 10, 9019, Tromsø, Norway.
  • Konieczny J; Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH2 building level 10, 9019, Tromsø, Norway.
  • Vázquez E; Genomics Unit, CNIC, 28029, Madrid, Spain.
  • Rubio A; Area of Cell and Developmental Biology, CNIC, 28029, Madrid, Spain.
  • Utnes P; Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH2 building level 10, 9019, Tromsø, Norway.
  • Tello A; Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH2 building level 10, 9019, Tromsø, Norway.
  • You X; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, 53705, USA.
  • Fenton CG; Genomics Support Center Tromsø, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH building level 9, 9019, Tromsø, Norway.
  • Paulssen RH; Genomics Support Center Tromsø, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH building level 9, 9019, Tromsø, Norway.
  • Zhang J; Clinical Bioinformatics Research Group, Department of Clinical Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH building level 9, 9019, Tromsø, Norway.
  • Sánchez-Cabo F; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, 53705, USA.
  • Dopazo A; Bioinformatics Unit, Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029, Madrid, Spain.
  • Vik A; Genomics Unit, CNIC, 28029, Madrid, Spain.
  • Anderssen E; Department of Hematology, University Hospital of North Norway, 9019, Tromsø, Norway.
  • Hidalgo A; Genomics Support Center Tromsø, Faculty of Health Sciences, UiT - The Arctic University of Norway, MH building level 9, 9019, Tromsø, Norway.
  • Arranz L; Area of Cell and Developmental Biology, CNIC, 28029, Madrid, Spain.
Nat Commun ; 14(1): 3874, 2023 Jun 30.
Article em En | MEDLINE | ID: mdl-37391415

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article